Akoya Biosciences Inc Asset Turnover Ratio (AKYA), as of first quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Akoya Biosciences Inc   (NASDAQ: AKYA)
 

Akoya Biosciences Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Akoya Biosciences Inc asset turnover ratio, the ability of Akoya Biosciences Inc 's assets to generate revenue in the first quarter 2025, increased sequentially to 0.62 in the first quarter (Mar 31 2025), a new company high.

Within sector 7 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2025, to 1701, from total ranking in the fourth quarter 2024 at 2247.

Asset Turnover Ratio Definition



AKYA Asset Turnover Ratio (Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
Y / Y Asset Change -27.21 % -22.03 % -25.9 % -22.52 % 0.29 %
Y / Y Revenue Change -8.68 % -15.47 % -22.87 % -3.16 % -18.83 %
Asset Turnover Ratio (TTM) 0.62 0.58 0.57 0.57 0.54
AKYA's Total Ranking # 1701 # 2247 # 2331 # 1575 # 1604
Seq. Asset Change -9.88 % -4.82 % -9.68 % -6.03 % -3.48 %
Seq. Revenue Change -29.11 % 19.57 % -16.36 % 28.81 % -34.39 %



Asset Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 8
Healthcare Sector # 227
Overall Market # 1701

Asset Turnover Ratio Statistics
High Average Low
0.62 0.46 0.31
(Mar 31 2025)   (Mar 31 2022)







Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2025 Assets at quarter ending Mar 31 2025
Nature s Sunshine Products inc   1.87 $ 455.307  Millions$ 243.680  Millions
Dih Holding Us Inc   1.84 $ 62.214  Millions$ 33.828  Millions
P3 Health Partners Inc   1.80 $ 1,485.192  Millions$ 823.346  Millions
Progyny Inc   1.80 $ 1,212.752  Millions$ 673.998  Millions
Aspira Women s Health inc   1.77 $ 9.275  Millions$ 5.232  Millions
Encision Inc   1.76 $ 6.555  Millions$ 3.718  Millions
Regen Biopharma Inc   1.76 $ 0.291  Millions$ 0.165  Millions
Rockwell Medical inc   1.75 $ 97.462  Millions$ 55.820  Millions
Quipt Home Medical Corp   1.73 $ 425.431  Millions$ 245.529  Millions
Medinotec Inc   1.72 $ 9.114  Millions$ 5.308  Millions
Cv Sciences Inc   1.70 $ 13.973  Millions$ 8.241  Millions
International Stem Cell Corporation  1.68 $ 9.085  Millions$ 5.393  Millions
Vycor Medical Inc   1.68 $ 1.689  Millions$ 1.003  Millions
Sunlink Health Systems Inc   1.68 $ 31.774  Millions$ 18.897  Millions
Privia Health Group Inc   1.59 $ 1,801.244  Millions$ 1,135.627  Millions
Innovage Holding Corp   1.56 $ 831.684  Millions$ 534.203  Millions
Iridex Corp  1.54 $ 48.099  Millions$ 31.193  Millions
Option Care Health Inc   1.54 $ 5,185.674  Millions$ 3,376.644  Millions
Marpai Inc  1.53 $ 26.206  Millions$ 17.105  Millions
Kewaunee Scientific Corporation  1.48 $ 239.857  Millions$ 162.575  Millions
Zynex inc   1.45 $ 172.452  Millions$ 118.953  Millions
Chemed Corporation  1.44 $ 2,488.997  Millions$ 1,724.877  Millions
Talkspace Inc   1.42 $ 193.386  Millions$ 136.236  Millions
Sbc Medical Group Holdings Incorporated  1.41 $ 304.886  Millions$ 216.673  Millions
Bioaffinity Technologies Inc   1.39 $ 8.809  Millions$ 6.317  Millions
Sanuwave Health Inc   1.39 $ 36.190  Millions$ 25.958  Millions
Adm Tronics Unlimited Inc   1.39 $ 3.197  Millions$ 2.295  Millions
Mimedx Group Inc   1.39 $ 350.640  Millions$ 252.102  Millions
Neuroone Medical Technologies Corp  1.36 $ 6.864  Millions$ 5.034  Millions
Viemed Healthcare Inc   1.35 $ 232.793  Millions$ 172.155  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.